Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
14.87
-0.90 (-5.71%)
Aug 20, 2026, 3:27 PM EDT - Market open
Monte Rosa Therapeutics Market Cap
Monte Rosa Therapeutics has a market cap or net worth of $1.27 billion as of August 20, 2026. Its market cap has increased by 366.85% in one year.
Market Cap
1.27B
Enterprise Value
685.49M
1-Year Change
366.85%
Ranking
Category
Stock Price
$14.87
ChartMarket Cap Chart
Since the IPO on June 24, 2021, Monte Rosa Therapeutics's market cap has increased from $845.31M to $1.27B, an increase of 50.08%. That is a compound annual growth rate of 8.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 1.27B | 24.25% |
| Dec 31, 2025 | 1.02B | 139.48% |
| Dec 31, 2024 | 426.37M | 50.74% |
| Dec 29, 2023 | 282.85M | -23.21% |
| Dec 30, 2022 | 368.32M | -61.22% |
| Dec 31, 2021 | 949.65M | 12.34% |
| Jun 24, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Savara | 1.42B |
| MannKind | 1.41B |
| Replimune Group | 1.40B |
| Vor Biopharma | 1.40B |
| Aktis Oncology | 1.39B |
| Alto Neuroscience | 1.37B |
| Alpha Tau Medical | 1.34B |
| Omeros | 1.33B |